General Info

Established in 2002, EnteroMedics develops and commercializes a new therapeutic platform for the treatment of a range of acute and chronic diseases that are mediated by vagal nerves. The company offers surgical management services for people who suffer from obesity. It conducts in-depth analysis to determine the effect of vagus nerves on food intake and processing. EnteroMedics also offers VBLOC therapy, which is designed to control nerve and organ functions. It provides online information related to gastric bypass, laparoscopic gastric band and bariatric weight loss surgeries. The company employs more than 70 professionals who specialize in the areas of technology development, clinical evaluation and applied research.